Biologist Eugene Bell and his colleagues report a method for repairing wounds with artificial skin made from an individual's own cells. Bell then founds Organogenesis, which in 1998 becomes the first company to receive US Food and Drug Administration approval for a medical product containing living cells.
A paper by Harvard Medical School researcher Joseph Vacanti and his team includes an image of what appears to be a human
ear growing out of a mouse's back. The team hopes that its research will lead to lab-grown ears for people whose ears are damaged. But the image sparks a backlash from animal rights activists and people who find the image shocking.
Two teams announce that they have isolated human embryonic stem cells (pictured 
1952
US scientists Robert Briggs and Thomas King report the first cloning using nuclear transfer. The researchers remove the nucleus from a frog egg and replace it with the nucleus from a frog-embryo cell. The egg develops into a tadpole. The experiment shows that nuclei hold onto the organism's genome even after they have been transferred into a new cell body. Briggs's initial request for funds is dismissed by the US National Cancer Institute, which called nuclear transplantation a "hare-brained scheme".
In one of the first surgical textbooks, Indian surgeon Suśruta (pictured) discusses skin-graft techniques. The book details a method for repairing torn earlobes with skin from the cheek and includes the first written record of reconstruction of the nose from a flap of forehead skin.
1998 
LARGE-SCALE SUCCESS
An individual with a spinal-cord injury becomes the first person to receive a therapy derived from embryonic stem cells. A large study the same year reports that stem cells harvested from patients' healthy cornea tissue can be grown in the lab and transplanted into the damaged corneas to restore eyesight.
FIRST TO MARKET
The Europe Commission approves the sale of Holoclar to treat people with severely damaged corneas. It is the first stem-cell therapy to reach the market.
Shoukhrat Mitalipov at Oregon Health and Science University in Portland and his colleagues create the first human stem-cell lines by therapeutic cloning. The process involves somatic-cell nuclear transfer (pictured) -the same technique used to clone Dolly the sheep. First, researchers take the nucleus from a donor cell and inject it into an egg from which the nucleus has been removed. 
